Treatment with thrombolytic therapy may protect against these occurrence.

Treatment with thrombolytic therapy may protect against these occurrence , but can pose a bleeding. Therefore, Dr. Chang and colleagues sought to develop a safe, effective and affordable thrombolytic therapy for DVT.

– The results of the study showed that the blood flow throughout the deep venous system in 16 of the 20 patients during therapy with complete resolution of symptoms in 18 patients was restored after six months of anticoagulation. Alteplase was from the patient’s circulation system cleared within two hours after the treatment, making. Risk of bleeding There were no serious complications or bleeding during treatment , and no cases of post-thrombotic syndrome or recurrent bleeding during the follow-up of 3.4 years – .. Twenty patients with acute DVT were treated with direct intraclot lacing of the thrombus with a clot-dissolving agent called alteplase and full systemic anticoagulation. Alteplase binds to the clot, so that the method does not require a continuous infusion of the drug, as some thrombolytic therapies. Continue reading “Treatment with thrombolytic therapy may protect against these occurrence.”